Funding Opportunities

Increasing Immediate Engagement and Retention in HIV Treatment with Substance Users (R01- Clinical Trials Required)

RFA-DA-23-002

NIH

Letter of Intent Deadline: Jul 11 2022

Application Deadline: Aug 11 2022 at 5:00pm

Increasing Immediate Engagement and Retention in HIV Treatment with Substance Users (R01- Clinical

Funding Opportunity Purpose

The purpose of the Funding Opportunity Announcement (FOA) is to support research that addresses limitations in understanding how to ensure all people who use drugs (PWUD) and are at risk for, or living with HIV have rapid access to high quality substance use disorder (SUD) treatment and HIV care services, including Pre-exposure prophylaxis (PrEP). This FOA is intended to support research that develops and tests interventions at the system, organization, provider, and/or social determinants of health levels to reduce the time between HIV testing and/or diagnosis and linkage to appropriate HIV care for PWUD. In addition to rapid HIV care, projects supported through this FOA should also address the identification of SUD service needs and rapid linkage to appropriate services. Because access to care is also impacted by sex, gender identity, sexual orientation, and race/ethnicity structural and systems-level interventions paying special attention to equity will be given priority consideration for funding.

Learn More